Loading
Latest filing published 22 May 2026 for 판타지오. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 미래아이앤지 across 3 companies, led by 판타지오, 케이바이오랩스 and 미래아이앤지. The record holds 33 filings, for trades running from 7 May 2021 to 22 May 2026.
Market trades split into 14 purchases (€8.4M) and 4 sales. The totals do not cover 16 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 4 purchases and 3 sales.
No cluster: in 7 purchases, no other insider of the company bought within 30 days.
The newest entry dates from 22 May 2026: an open-market sale, in 판타지오. The clock since the last published purchase (27 April 2026) now reads 174 days. Between a trade and the moment it shows up on DART (FSS), the median delay is 4 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations